{"entity":{"id":"salubris-biotherapeutics","kind":"company","name":"Salubris Biotherapeutics","aka":["SalubrisBio"],"tldr":"Salubris Biotherapeutics is a US-based biotechnology company that leads 2 cancer trials in OnCo, testing the biologics JK06 and JK08 in melanoma, colorectal cancer, non-small-cell lung cancer, small-cell lung cancer and advanced solid tumours.","summary":"Salubris Biotherapeutics (SalubrisBio) is a clinical-stage biotechnology company founded in 2016 that discovers and develops antibody and protein-based biologics for cardiovascular disease and oncology. Its pipeline includes JK06, JK07 and JK08. It is the US subsidiary of Salubris Pharmaceuticals of Shenzhen. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT06667960 (phase 1/2, Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer) and NCT05620134 (phase 1/2, Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-17","links":[{"label":"Official website","url":"https://www.salubrisbio.com/"},{"label":"ClinicalTrials.gov: trials led by Salubris Biotherapeutics","url":"https://clinicaltrials.gov/search?lead=Salubris%20Biotherapeutics%20Inc"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["melanoma","colorectal","nsclc","sclc"],"sections":[],"technologies":[],"targets":[],"drugs":["jk08","pembrolizumab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06667960","nct05620134"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo orphan-trial linking round (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-17"},"hq":"Gaithersburg, Maryland","country":"US","companyType":"biotech","website":"https://www.salubrisbio.com/","founded":2016,"stage":"growth","investors":[],"funding":[]},"route":"/companies/salubris-biotherapeutics/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"jk08","kind":"drug","name":"JK08","route":"/drugs/jk08/"},{"id":"pembrolizumab","kind":"drug","name":"Pembrolizumab","route":"/drugs/pembrolizumab/"}],"trial":[{"id":"nct06667960","kind":"trial","name":"Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer","route":"/trials/nct06667960/"},{"id":"nct05620134","kind":"trial","name":"Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer","route":"/trials/nct05620134/"}]}}